RIFAMPICIN - A CLINICAL SURVEY

被引：0
|
作者：
BERGAMINI, N
BACHINI, V
FERRARIO, A
INNOCENTI, G
FOWST, G
机构：
来源：
ARZNEIMITTEL-FORSCHUNG | 1970年 / 20卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1546 / +
页数：1
相关论文
共 50 条
  • [41] Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies
    Hashimoto, Satsuki
    Honda, Kyoko
    Fujita, Kohei
    Miyachi, Yuka
    Isoda, Kazuya
    Misaka, Ko
    Suga, Yukio
    Kato, Satoshi
    Tsuchiya, Hiroyuki
    Kato, Yukio
    Okajima, Masaki
    Taniguchi, Takumi
    Shimada, Tsutomu
    Sai, Yoshimichi
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2018, 4
  • [42] Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
    Oguz Karabay
    Irfan Sencan
    Derya Kayas
    Idris Şahin
    BMC Infectious Diseases, 4
  • [43] Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
    Karabay, O
    Sencan, I
    Kayas, D
    Sahin, I
    BMC INFECTIOUS DISEASES, 2004, 4 (1)
  • [44] ACUTE RENAL-FAILURE AFTER RIFAMPICIN - CASE REPORT AND SURVEY OF LITERATURE
    NESSI, R
    BONOLDI, GL
    REDAELLI, B
    DIFILIPPO, G
    NEPHRON, 1976, 16 (02): : 148 - 159
  • [45] Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis
    Skoczynska, A.
    Ruckly, C.
    Hong, E.
    Taha, M-K.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (12) : 1178 - 1181
  • [46] RIFAMPICIN QUINONE IS AN IMMUNOSUPPRESSANT, BUT NOT RIFAMPICIN ITSELF
    KONRAD, P
    STENBERG, P
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 46 (01): : 162 - 166
  • [47] Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients
    Verbeeck, Roger K.
    Singu, Bonifasius S.
    Kibuule, Dan
    CLINICAL PHARMACOKINETICS, 2019, 58 (12) : 1511 - 1515
  • [48] Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients
    Roger K. Verbeeck
    Bonifasius S. Singu
    Dan Kibuule
    Clinical Pharmacokinetics, 2019, 58 : 1511 - 1515
  • [49] HEPATOTOXIC SIDE-EFFECTS OF RIFAMPICIN - COMPARATIVE CLINICAL-STUDY
    KUNTZ, HD
    RAUSCH, V
    MEDIZINISCHE WELT, 1977, 28 (47): : 1940 - 1942
  • [50] In vitro effect of moxifloxacin and rifampicin on biofilm formation by clinical MRSA isolates
    Ozturk, I
    Yurtman, A. N.
    Erac, B.
    Gul-Yurtsever, S.
    Ermertcan, S.
    Hosgor-Limoncu, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2014, 115 (08): : 483 - 486
12345